Pancreatic Cancer Research

ResearcherThe University of OsakaActive in the last 2 years

Keisuke Toya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4275-3209; OpenAlex author ID A5019625692. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. A soft tissue mass around the arteries after pancreatectomy: the association with local recurrence and the impact of neoadjuvant radiotherapy in pancreatic duc… Co-author DOI 10.1007/s00595-026-03341-w↗
  2. Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma U… Co-author DOI 10.1245/s10434-022-12985-0↗
  3. ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancre… Co-author DOI 10.1245/s10434-022-13024-8↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuichiro Doki · 3 shared papers, 2023–2026 · strength 0.59
  2. Hidetoshi Eguchi · 3 shared papers, 2023–2026 · strength 0.59
  3. Yoshito Tomimaru · 3 shared papers, 2023–2026 · strength 0.59
  4. Daisaku Yamada · 3 shared papers, 2023–2026 · strength 0.59
  5. Masahiro Tanemura · 2 shared papers, 2023 · strength 0.32
  6. Tadafumi Asaoka · 2 shared papers, 2023 · strength 0.32
  7. Yoshifumi Iwagami · 2 shared papers, 2023 · strength 0.32
  8. Shohei Takaichi · 2 shared papers, 2023 · strength 0.32
  9. Hidenori Takahashi · 2 shared papers, 2023 · strength 0.32
  10. Kazuki Sasaki · 2 shared papers, 2023 · strength 0.32
  11. Shinichiro Hasegawa · 1 shared paper, 2026 · strength 0.27
  12. Hirofumi Akita · 1 shared paper, 2026 · strength 0.27
  13. Yosuke Mukai · 1 shared paper, 2026 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.